Additive effects of moderate drinking and obesity on serum γ-glutamyl transferase

American Journal of Clinical Nutrition

Volumn 83, Issue 6, 2006, Pages 1252-1253

  Seitz, Helmut K ^a  

^a Krankenhaus Salem   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2E1; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE;

ALCOHOL CONSUMPTION; DISEASE SEVERITY; DRINKING BEHAVIOR; EDITORIAL; ENZYME ACTIVITY; ENZYME INDUCTION; FIBROSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; ULTRASOUND; ALCOHOLIC FATTY LIVER; BLOOD; BODY MASS; ENZYMOLOGY; LIVER FUNCTION TEST; METABOLISM; NOTE;

ALCOHOL DRINKING; BODY MASS INDEX; FATTY LIVER, ALCOHOLIC; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER FUNCTION TESTS; OBESITY;

EID: 33745625919     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.6.1252     Document Type: Editorial

References (10)

1. Bell H, Tallaksen C, Sjaheim T. Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver disease. Alcohol Clin Exp Res 1993;17:246-52.
2. McIntyre N, Rosalki S. Biochemical investigations in the management of liver disease. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. New York, NY: Oxford University Press, 1991:293-309.
3. Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemelä O. Additive effects of moderate drinking and obesity on serum γ-glutamyl transferase activity. Am J Clin Nutr 2006;83:1351-4.
4. Lieber CS. CYP 2E1: from ASH to NASH. Hepatol Res 2004;28:1-11.
5. Clot P, Bellomo G, Tabone M, Arico S, Albano E. Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology 1995;108:210-7.
6. 6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepatocarcinogenesis. Carcinogenesis 2004;25:1027-31.
7. Speisky H, Shackel N, Varghese G, Wade D, Israel Y. Role of hepatic gamma-glutamyltransferase in the degradation of circulating glutathione: studies in the intact guinea pig perfused liver. Hepatology 1990;11:243-9.
8. Oneta C, Lieber CS, Li JJ, et al. Dynamics of cytochrome P4502E1 activity in men: induction by ethanol and disappearance during withdrawal phase. J Hepatol 2002;36:47-52.
9. Weltman MD, Farrel GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-33.
10. Becker U, Deis A, Sörensen TIA, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23:1025-9.